The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Ionis Pharmaceuticals Inc shares valued at $234,959 were sold by Swayze Eric on Jan 16 ’25. At $32.84 per share, Swayze Eric sold 7,154 shares. The insider’s holdings dropped to 45,670 shares worth approximately $1.48 million following the completion of this transaction.
Also, Swayze Eric sold 22 shares, netting a total of over 719 in proceeds. Following the sale of shares at $32.70 each, the insider now holds 184 shares.
Before that, Schneider Eugene had sold 6,523 shares from its account. In a trade valued at $213,889, the EVP, Chf Clinical Develop Ofcr traded Ionis Pharmaceuticals Inc shares for $32.79 each. Upon closing the transaction, the insider’s holdings decreased to 6,523 shares, worth approximately $1.9 million.
As published in a research note from BMO Capital Markets on August 02, 2024, Ionis Pharmaceuticals Inc [IONS] has been rated down from an Outperform to a Market perform and the price target has been revised to $60 from $67. Analysts at Leerink Partners upgraded the stock from ‘”a Market perform”‘ to ‘”an Outperform”‘ outlook in a report released in late July. Earlier on June 14, 2024, Bernstein upgraded its rating. Their new recommendation was “a Mkt perform” for IONS stock which previously was a “an Underperform”.
Analyzing IONS Stock Performance
During the last five days, there has been a drop of approximately -0.58%. Over the course of the year, Ionis Pharmaceuticals Inc shares have dropped approximately -7.04%. Shares of the company reached a 52-week high of $35.47 on 01/02/25 and a 52-week low of $31.40 on 01/17/25. A 50-day SMA is recorded $35.66, while a 200-day SMA reached $41.08. Nevertheless, trading volume fell to 1.05 million shares from 1.54 million shares the previous day.
Support And Resistance Levels for Ionis Pharmaceuticals Inc (IONS)
According to the 24-hour chart, there is a support level at 32.27, which, if violated, would cause prices to drop to 32.04. In the upper region, resistance lies at 32.83. The next price resistance is at 33.16. RSI (Relative Strength Index) is 39.90 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.43, which suggests the price will decrease in the coming days. Percent R is at 74.48%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
